Evidence map›Paper›PMID 32804415›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2020

Repeating noninvasive risk stratification improves prediction of outcome in ICD patients.

Bert Vandenberk, Vincent Floré, Christian Röver, Mark A Vos, Albert Dunnink, Dionyssios Leftheriotis, Tim Friede, Panagiota Flevari, Markus Zabel, Rik Willems

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Repeating noninvasive risk stratification improves prediction of outcome in ICD patients.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Bert VandenberkDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.ORCID 0000-0001-8296-920X
Vincent FloréDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.ORCID 0000-0003-1245-8919
Christian RöverDepartment of Medical Statistics, University Medical Center Göttingen, Gottingen, The Netherlands.ORCID 0000-0002-6911-698X
Mark A VosDepartment of Physiology, University Medical Center Utrecht, UMCU, Utrecht, The Netherlands.
Albert DunninkDepartment of Physiology, University Medical Center Utrecht, UMCU, Utrecht, The Netherlands.
Dionyssios LeftheriotisDepartment of Cardiology, Attikon University Hospital, AUH, Athens, Greece.ORCID 0000-0002-3970-7842
Tim FriedeDepartment of Medical Statistics, University Medical Center Göttingen, Gottingen, The Netherlands.ORCID 0000-0001-5347-7441
Panagiota FlevariDepartment of Cardiology, Attikon University Hospital, AUH, Athens, Greece.
Markus ZabelDepartment of Cardiology, Heart Centre, University Medical Center Göttingen, Gottingen, The Netherlands.ORCID 0000-0003-0895-4602
Rik WillemsDepartment of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.ORCID 0000-0002-5469-9609
Universitair Ziekenhuis Leuven · BEUniversity General Hospital Attikon · GRUtrecht University · NLKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNoninvasive risk stratification aims to detect abnormalities in the pathophysiological mechanisms underlying ventricular arrhythmias. We studied the predictive value of repeating risk stratification in patients with an implantable cardioverter-defibrillator (ICD).

methodsThe EUTrigTreat clinical study was a prospective multicenter trial including ischemic and nonischemic cardiomyopathies and arrhythmogenic heart disease. Left ventricular ejection fraction ≤40% (LVEF), premature ventricular complexes >400/24 hr (PVC), non-negative microvolt T-wave alternans (MTWA), and abnormal heart rate turbulence (HRT) were considered high risk. Tests were repeated within 12 months after inclusion. Adjusted Cox regression analysis was performed for mortality and appropriate ICD shocks.

resultsIn total, 635 patients had analyzable baseline data with a median follow-up of 4.4 years. Worsening of LVEF was associated with increased mortality (HR 3.59, 95% CI 1.17-11.04), as was consistent abnormal HRT (HR 8.34, 95%CI 1.06-65.54). HRT improvement was associated with improved survival when compared to consistent abnormal HRT (HR 0.10, 95%CI 0.01-0.82). For appropriate ICD shocks, a non-negative MTWA test or high PVC count at any moment was associated with increased arrhythmic risk independent of the evolution of test results (worsening: HR 3.76 (95%CI 1.43-9.88) and HR 2.50 (95%CI 1.15-5.46); improvement: HR 2.80 (95%CI 1.03-7.61) and HR 2.45 (95%CI 1.07-5.62); consistent: HR 2.47 (95%CI 0.95-6.45) and HR 2.40 (95%CI 1.33-4.33), respectively). LVEF improvement was associated with a lower arrhythmic risk (HR 0.34, 95%CI 0.12-0.94).

conclusionsRepeating LVEF and HRT improved the prediction of mortality, whereas stratification of ventricular arrhythmias may be improved by repeating LVEF measurements, MTWA and ECG Holter monitoring.

Indexed as

Defibrillators, ImplantableAgedElectrocardiography, AmbulatoryEuropeFemaleFollow-Up StudiesHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesRisk AssessmentTachycardia, Ventricularautonomic functionheart rate turbulenceleft ventricular ejection fractionmicrovolt T-wave alternansnoninvasive risk stratificationsudden cardiac death

Identifiers

PMID32804415
PMCPMC7679829
OpenAlexW3075350353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.